One of our vaccine manufacturer partners, Sanofi Pasteur announced on Monday that the FDA approved the updated prescribing information for Fluzone® High-Dose vaccine for adults 65 and older. The revised vaccine information now Includes important new data showing Fluzone High-Dose Vaccine more efficacious than standard-dose Fluzone Vaccine. http://sanofipasteurus.mediaroom.com/index.php?s=11069&item=136697